Cargando…

Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity

Immunogenic tumor cell death enhances anti-tumor immunity. However, the mechanisms underlying this effect are incompletely understood. We established a system to induce tumor cell death in situ and investigated its effect on dendritic cell (DC) migration and T cell responses using intravital photola...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriya, Taiki, Kitagawa, Kurumi, Hayakawa, Yuuki, Hemmi, Hiroaki, Kaisho, Tsuneyasu, Ueha, Satoshi, Ikebuchi, Ryoyo, Yasuda, Ippei, Nakanishi, Yasutaka, Honda, Tetsuya, Matsushima, Koji, Kabashima, Kenji, Ueda, Mizuki, Kusumoto, Yutaka, Chtanova, Tatyana, Tomura, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102907/
https://www.ncbi.nlm.nih.gov/pubmed/33997702
http://dx.doi.org/10.1016/j.isci.2021.102424
Descripción
Sumario:Immunogenic tumor cell death enhances anti-tumor immunity. However, the mechanisms underlying this effect are incompletely understood. We established a system to induce tumor cell death in situ and investigated its effect on dendritic cell (DC) migration and T cell responses using intravital photolabeling in mice expressing KikGR photoconvertible protein. We demonstrate that tumor cell death induces phagocytosis of tumor cells by tumor-infiltrating (Ti)-DCs, and HMGB1-TLR4 and ATP-P2X7 receptor signaling-dependent Ti-DC emigration to draining lymph nodes (dLNs). This led to an increase in anti-tumor CD8(+) T cells of memory precursor effector phenotype and secondary tumor growth inhibition in a CD103(+) DC-dependent manner. However, combining tumor cell death induction with lipopolysaccharide treatment stimulated Ti-DC maturation and emigration to dLNs but did not improve tumor immunity. Thus, immunogenic tumor cell death enhances tumor immunity by increasing Ti-DC migration to dLNs where they promote anti-tumor T cell responses and tumor growth inhibition.